Zobrazeno 1 - 10
of 43
pro vyhledávání: '"I Adriaenssen"'
Publikováno v:
The European Journal of Health Economics. 4:271-278
Long-term comparative trials among newer antiepileptic drugs are lacking; therefore decision models are needed to guide treatment decisions. The goal of this study was to develop an economic model of newly diagnosed epilepsy in the UK and to provide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04295dfbfdd46fc36ee022904a7b09e8
https://doi.org/10.1007/s10198-003-0176-3
https://doi.org/10.1007/s10198-003-0176-3
Publikováno v:
Acta Neurologica Scandinavica. 108:9-15
Objectives – To evaluate the impact of different dosages of topiramate (TPM) add-on to stable antiepileptic therapy for refractory partial epilepsy in adults. Material and methods – Pooled intention-to-treat analysis of six similarly designed dou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d614ce04b4452a63b83eb2827689bd32
https://doi.org/10.1034/j.1600-0404.2003.00113.x
https://doi.org/10.1034/j.1600-0404.2003.00113.x
Publikováno v:
Journal of Medical Economics. 6:79-94
SUMMARYA decision analysis was performed to model the effects and health economic differences of current UK management approaches to attention-deficit/hyperactivity disorder (ADHD) in children aged between 6 and 16 years. The approaches modelled were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f925f77751d4cf63475d66fcfc442b3
https://doi.org/10.3111/200306079094
https://doi.org/10.3111/200306079094
Publikováno v:
Health Economics. 11:233-248
The problem of estimating expected outcomes for the economic evaluation of treatments for which the outcome of principal interest is (quality adjusted) survival time has so far not received sufficient attention in the literature. The best estimate of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::758cf90c1ef8abad5b95d0529a8eba26
https://doi.org/10.1002/hec.662
https://doi.org/10.1002/hec.662
Publikováno v:
European Journal of Cancer. 37:1768-1774
We present a retrospective cost-effectiveness analysis using data from a randomised controlled trial (EORTC 22863) of the addition of early hormonal therapy with a luteinising hormone-releasing horn-tone (LHRH) analogue to radiotherapy in the treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea1572e14a1da7210041b59de923a9d1
https://doi.org/10.1016/s0959-8049(01)00197-6
https://doi.org/10.1016/s0959-8049(01)00197-6
Autor:
I Adriaenssen, N Neymark
Publikováno v:
European Journal of Cancer. 35:1789-1795
With the aim of estimating and comparing the direct hospital costs of managing patients with advanced colorectal cancer in various countries, data on resource utilisation and unit prices were collected. Data on the consumption of medical resources we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c121e1850614da349ceec41933a30b
https://doi.org/10.1016/s0959-8049(99)00216-6
https://doi.org/10.1016/s0959-8049(99)00216-6
Publikováno v:
The European journal of health economics : HEPAC : health economics in prevention and care. 4(4)
Long-term comparative trials among newer antiepileptic drugs are lacking; therefore decision models are needed to guide treatment decisions. The goal of this study was to develop an economic model of newly diagnosed epilepsy in the UK and to provide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::23c2b63788b4ebf9065fa8e6adac8961
https://pubmed.ncbi.nlm.nih.gov/15609195
https://pubmed.ncbi.nlm.nih.gov/15609195
Publikováno v:
Acta neurologica Scandinavica. 108(1)
To evaluate the impact of different dosages of topiramate (TPM) add-on to stable antiepileptic therapy for refractory partial epilepsy in adults.Pooled intention-to-treat analysis of six similarly designed double-blind, placebo-controlled trials, inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f6e8e7cae1f03dba7e83477e1de780c1
https://pubmed.ncbi.nlm.nih.gov/12807387
https://pubmed.ncbi.nlm.nih.gov/12807387
Publikováno v:
Value in Health. 6(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d327fdab3d068ad7d7abc3616a1973f1
Publikováno v:
European journal of cancer (Oxford, England : 1990). 37(14)
We present a retrospective cost-effectiveness analysis using data from a randomised controlled trial (EORTC 22863) of the addition of early hormonal therapy with a luteinising hormone-releasing hormone (LHRH) analogue to radiotherapy in the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::49a18cb4d61b89cc87178859f0800456
https://pubmed.ncbi.nlm.nih.gov/11549430
https://pubmed.ncbi.nlm.nih.gov/11549430